B2B ad examples

Staan de juiste hulpmiddelen op de juiste plek? De hulpmiddelenscan laat zien wat er aanwezig is, hoe hulpmiddelen worden ingezet en waar kansen liggen om ze slimmer te verdelen. Zo stem je je hulpmiddelenbestand beter af op de zorgvraag.

Weet je welke hulpmiddelen beschikbaar zijn, waar ze worden ingezet en of ze nog aansluiten op de zorgvraag? Met de hulpmiddelenscan brengt HartingBank je hulpmiddelenbestand in kaart. Zo krijg je overzicht, inzicht en grip op wat je organisatie echt nodig heeft.

Cuando las condiciones clínicas cambian rápidamente, es fundamental tomar decisiones con confianza. Cardiohelp II facilita la toma de decisiones clínicas informadas mediante monitorización continua, visualización clara de tendencias e integración de NIRS para ayudar a evaluar la oxigenación tisular en tiempo real. Respaldando decisiones seguras y fundamentadas en situaciones críticas. Aprenda más sobre Cardiohelp II: https://lnkd.in/dVk6Fu-h

Wanneer de klinische condities snel veranderen, moeten beslissingen met vertrouwen genomen worden. Cardiohelp II ondersteunt weloverwogen, klinische besluitvorming door middel van continue monitoring, duidelijke trendinzichten en geïntegreerde NIRS om de weefseloxygenatie direct te beoordelen. Ondersteuning voor zelfverzekerde en weloverwogen beslissingen in tijdskritieke situaties. Meer informatie over Cardiohelp II: https://lnkd.in/dGpTdy3G

Govern AI where options become product. For AI-led experiences, the design system is a control point. Emids designs governance, trust, and human judgment into what can ship.

Bring one roadmap bet. Emids combines healthcare research, senior UX judgment, and AI-accelerated prototyping to challenge it before build.

🚀 Ready to bring your next big idea to market? Let's make it happen together. Meet Fertin Pharma at SupplySide Global, Booth 6247, to explore market-ready concepts or discuss your next product innovation. Discover advanced solutions within: ✅ Energy & Focus ✅ Cognitive Health ✅ Electrolytes & Hydration ✅ Beauty from Within ✅ Oral Care & Fresh Breath Let’s talk about what’s next for your consumer health brand. 📍 Mandalay Bay, Las Vegas, USA 📅 October 28–30, 2026 📌 Booth 6247 #SupplySideGlobal #ConsumerHealth #ProductInnovation #CDMO #Fertin

The future of pharma growth will be built through partnerships. At Farmaprojects | Polpharma Group, we believe the best innovations are built together. As a leading pan-European pharmaceutical player, with a consolidated footprint and a well-established leadership position in CEE, Polpharma Group combines deep pharmaceutical expertise, world-class development and manufacturing capabilities, and a long-term commitment to global collaboration. As part of our Strategic Partnerships initiative, we're actively seeking collaboration opportunities in: ✅ Hard-to-make Rx ✅ Complex injectables ✅ US-focused partnerships ✅ Co-development opportunities that accelerate access to new pipeline and markets Our goal is simple: combine synergies to bring differentiated medicines to patients faster. If this resonates with your objectives, reach out to Bernardo Reiner, Ana Patrícia Freitas Rei or Jorge Espírito Santo

Microbiota and metabolomics research depends on more than the analytical method. Sample collection and pre-analytical workflows can influence the data available for interpretation. Join Julia Kuligowski, Senior Researcher at the Health Research Institute La Fe, for an Invitek Talk on sample collection, gut microbiota and biomarkers in clinical research. 3 November | 10:00 CET | 45-minute live webinar Register to attend.

We'll be at ANCC - American Nurses Credentialing Center Magnet & Pathway Conference in Chicago at the end of this month! Join us for in-booth demos, giveaways, grand prizes, or just to say hello. We hope to see you there!

Wie lässt sich High-Flow-Therapie auch während des innerklinischen Transports aufrechterhalten? Patiententransporte gehören zum Klinikalltag. Die Herausforderung: Die Therapie sollte den Patienten begleiten, nicht am Bett enden. Der HAMILTON-HF90 wurde entwickelt, um HFOT auch während innerklinischer Transporte bereitzustellen. Mit seiner optionalen Batterie ermöglicht das System einen netzunabhängigen Betrieb von bis zu zwei Stunden und unterstützt so Therapiekontinuität über verschiedene Versorgungsbereiche hinweg. 👉Wie organisiert Ihr Team aktuell die High-Flow-Therapie bei Patiententransporten? Informieren Sie sich über die Einsatzmöglichkeiten des HAMILTON-HF90. https://okt.to/Mi3sgb #HighFlowOxygenTherapy #HFOT #HamiltonMedical #HAMILTONHF90

How much can sample collection influence biomarker research? Pre-analytical workflows can affect the microbiota and metabolomics data available for interpretation. Join Julia Kuligowski, Senior Researcher at the Health Research Institute La Fe, for an Invitek Talk on sample collection, gut microbiota and biomarkers in clinical research. 3 November | 10:00 CET | 45-minute live webinar Register to attend.

Un año más, Fresenius Kabi España estará presente en el 67º Congreso de la Sociedad Española de Endocrinología y Nutrición (SEEN), que se celebrará del 21 al 23 de octubre en Santiago de Compostela. Este encuentro reunirá a profesionales de la Endocrinología y la Nutrición para abordar algunos de los principales retos de la especialidad, entre ellos la nutrición clínica y la desnutrición relacionada con la enfermedad. Estaremos allí para escuchar, aprender, compartir conocimiento y reencontrarnos con muchos de los profesionales que impulsan cada día la Endocrinología y la Nutrición en nuestro país. 📍 Palacio de Congresos y Exposiciones de Galicia, Santiago de Compostela 📅 21–23 de octubre de 2026 ¡Os esperamos en el stand 1 de Fresenius Kabi!

Hello Alpha gives digital platforms the licensed providers, clinical workflows, medical oversight, and infrastructure to bring care directly into the experience they’ve already built. Launch in weeks. Keep your interface and brand. Give users access to care without sending them somewhere else. See how Hello Alpha fits into your platform.

A single cancer cell can display thousands of proteins, but very few of them justify years of drug development. Target selection depends on a combination of factors: does the molecule contribute to the disease, is its expression meaningfully higher in tumor than in healthy tissue, can the chosen therapeutic modality reach it, and is it present in a clinically relevant patient population? For targeted therapies, tumor specificity is particularly important because on-target, off-tumor activity can create significant toxicity. CEACAM6 is one example of a target that has drawn growing interest against these criteria. It is overexpressed across several epithelial cancers and associated with poorer outcomes, signals through pathways involved in proliferation, invasion and angiogenesis, has been linked to reduced chemosensitivity, and has also been implicated in immune evasion through interaction with CEACAM1 on activated T cells. Its cell-surface expression also makes it accessible to targeted therapeutic approaches. What makes a strong target valuable is that it is not tied to a single technology. CEACAM6 has been explored through antibody-drug conjugates, nanobody-based formats, targeted nucleic acid delivery, and immunoconjugates designed to modify the acidic tumor microenvironment rather than directly kill tumor cells. The most effective therapeutic strategies do not begin with a modality. They behind with biology that is understood well enough to determine where, and how, to intervene. At Helix BioPharma, our work begins with that principle: understanding tumor biology deeply enough to identify where intervention may matter most, and designing therapeutic strategies around it. For a deeper look at CEACAM6 as a therapeutic target, explore our presentation from World ADC London 2026: https://lnkd.in/dnSN772m #CancerBiology #Oncology #CancerResearch #TranslationalMedicine #TargetedTherapy #PrecisionOncology #MedicalInnovation #Biotechnology #FutureOfMedicine

You’ve built the member experience. We make clinical care possible inside it. Hello Alpha powers the providers, care pathways, medical oversight, prescribing, follow-up, and clinical operations behind the scenes, while your brand stays front and center.

The Counselor will conduct patient assessments, including level of care appropriateness, risks, and strengths. This role requires demonstrated knowledge of the disease of addiction, twelve-step recovery principles, addiction and/or mental health treatment, and other evidence-based practices in related clinical issues. The Counselor will promote recovery through role-modeling and respectful interactions with patients and colleagues.

Decoding Tumor-Immune Interactions Through Multi-Omic Signals The future of precision oncology depends not only on identifying genomic alterations, but also on understanding how tumor biology interacts with the immune system. At the Gene Solutions Industry Satellite Symposium during ESMO - European Society for Medical Oncology Congress 2026, Prof. Aya El Helali of The University of Hong Kong, Hong Kong SAR, will explore how multi-omic signals can deepen our understanding of cancer biology and support immunogenetic discovery. Presentation topic: The Role of Multi-Omic Signals for Next Generation Precision Oncology and Immunogenetic Discovery “The next frontier of precision oncology lies in deciphering the complex interplay between tumor biology and the immune system. By integrating genomic, transcriptomic, and immunogenetic information, multi-omic profiling can help characterize neoantigen profiles, the tumor microenvironment, and immune checkpoint expression. These deeper insights may open new directions for biomarker discovery and more personalized therapeutic strategies.” Drawing on ongoing research and multi-omic analyses, Prof. Aya El Helali will discuss how immunogenetic insights may contribute to biomarker discovery, therapeutic research, and the next generation of precision oncology. Join Prof. Aya El Helali for a forward-looking discussion on how deeper molecular intelligence can help reveal the relationship between tumor biology and the immune system, bringing precision oncology closer to more individualized therapeutic strategies. 👇Gene Solutions Industry Satellite Symposium ▪️Topic: AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation ▪️Date: Friday, 23 October 2026 ▪️Time: 09:45–11:15 CEST ▪️Location: Salamanca Auditorium, Hall 10 🔗 Register now to stay up to date with the latest scientific insights from Gene Solutions’ Industry Satellite Symposium at ESMO Congress 2026: https://lnkd.in/gNAtBb5D 🔗 ESMO session link: https://lnkd.in/dGWkW9Um #ESMO26 #PrecisionOncology #MultiOmics #Immunogenetics #Neoantigens #TumorMicroenvironment #CancerResearch #GeneSolutions This non-promotional medical educational symposium is organized and funded by Gene Solutions for healthcare professionals only.

Le 18 novembre, à l’hôpital Saint-Joseph de Marseille, plusieurs médecins racontent ce que l'IA change pour le soin. Places limitées, entrée gratuite.

7 retours d'expérience de médecins sur ce que change l'IA médicale dans la pratique. A ne pas manquer le 18 novembre à Marseille.

After a very meaningful chapter at Fresenius Kabi, I have decided to leave the company and pursue a change in my professional life. This has been a deeply personal decision, made with enormous respect for the business, its people and everything we have achieved together. As I look back on this chapter and as someone who loves hiking, one image stays with me: no one reaches the summit alone. It is the rope team that matters. I have been fortunate to be part of an extraordinary team at Fresenius Kabi, and I leave with deep gratitude for every step we took together. I leave with a full heart and enormous appreciation for everyone who has been part of my journey at Fresenius Kabi. My thanks to Michael Sen and Wolfgang Kirsch for their trust and support over the many years. I am pleased to hand over to Marc-Alexander Mahl, who knows our business and has been an important member of our leadership team. I am confident that he will provide strong continuity for the next chapter. With gratitude.

Cuando pensamos en anestesia, solemos pensar en quedarnos dormidos. Pero la anestesiología va mucho más allá. Con motivo del Día Mundial de la Anestesiología, ponemos el foco en una especialidad esencial para la seguridad y el bienestar de los pacientes durante una intervención quirúrgica. En este vídeo, el Dr. Alex Barroso, anestesiólogo y especialista en Medicina del Dolor del Hospital Regional Universitario de Málaga, explica cómo la monitorización de la actividad cerebral puede aportar información relevante durante una cirugía, ayudando a los profesionales sanitarios en la toma de decisiones clínicas. Además, aborda el potencial de herramientas como el electroencefalograma (EEG) para comprender mejor la respuesta del organismo durante la intervención y el papel que tecnologías emergentes, como la inteligencia artificial, podrían desempeñar en el futuro de la anestesiología. #DíaMundialDeLaAnestesiología

Some occasions deserve more than words. They deserve to be remembered ✨ This year's edition of CPHI Milan was one of them. A chance to celebrate how far we've come and look ahead to what's still to come, while doing what we do best: creating opportunities and building connections that truly matter. Here's a glimpse of what made it so special 🥂 #WeAreActive #Flarer #CPHI #Anniversary

In Spain, GCP inspections are usually notified in advance, but they can also be unannounced. If an inspector asks how a document got from your centre to the sponsor's file, the answer has to exist already. The guide turns ICH E6(R3) into four questions your team can test itself on.